BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

MEDICINES COMPANY — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Termination

MEDICINES COMPANY

via PETER TEELEY

2nd Quarter (Apr 1 - June 30) · 2010Posted Aug 20, 2010Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: MEDICINES COMPANY
Location: New Jersey · United States of America

Registrant

Firm: PETER TEELEY
Location: BETHESDA, Maryland, United States of America

Lobbying activities

1 issue

Copyright/Patent/Trademark
Issues related to the Hatch-Waxman Act; proposed clarifying amendment to 3 U.S.C. 156.
LobbyistsPETER TEELEY

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.